Innovassynth Technologies (India) Ltd
- Market cap
- ₹ 1,460 Cr.
- P/E
- 266.7x
- P/B
- 14.25x
- ROE
- −41%
- ROCE
- −25%
- Dividend yield
- 0%
- Debt / equity
- 1.19
- Sector
- Chemicals & Petrochemicals
- Industry
- Commodity Chemicals
- Listed on
- BSE
About
Innovassynth Technologies (India) Limited, formerly Innovassynth Investments Limited, is an India-based company, which is engaged in developing, scaling up and manufacturing of specialty chemicals and pharmaceuticals intermediates. The Company is engaged in custom development and manufacturing. It partners with pharma and diagnostics, organometallics, petrochemical and polymers, flavors and fragrance, and specialty chemical companies worldwide. Through its two business verticals, the Company offers solutions and a range organic chemical portfolio: life sciences - nucleosides and specialty chemicals. Its Life Sciences - Nucleosides vertical includes Nucleosides - Phosphoramidite, Delivery Platforms (GalNAc), Pharma Intermediates, Nucleosides - Reagents & Bio-buffers, and ADC Linkers. Its specialty chemicals include organometallics including pre-catalysts for metallocene, ZN catalysts and donors, polymers additives, ALD/CVD precursors, donors & ligands, and semiconductor chemicals.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Commodity Chemicals: 75 companies →Innovassynth Technologies (India) Ltd against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)266.7 against a typical 22.7: pricier than most peers (1st = cheapest).67th of 72
- Sales growth+356.3% against a typical +12.7% from a year earlier.3rd of 65
- Size₹ 1,459.8 Cr. market value against a typical ₹ 131.2 Cr. (1st = largest).7th of 69
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 50 | 0 | 12 | 17 | 22 | 51 | 56 |
| Expenses | 0 | 0 | 0 | 0 | 0 | 39 | 0 | 28 | 28 | 26 | 45 | 41 |
| Operating Profit | −0 | −0 | −0 | −0 | −0 | 11 | −0 | −16 | −11 | −4 | 6 | 15 |
| OPM % | — | — | — | — | — | 22.9% | — | −126.7% | −64.2% | −18.6% | 12.4% | 26.7% |
| Other Income | 0 | 0 | 0 | 0 | −0 | 1 | −0 | 0 | 0 | −0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 2 | 2 | 2 | 2 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | −0 | −0 | −0 | −0 | −1 | 9 | −0 | −19 | −15 | −8 | 2 | 11 |
| Tax % | 0% | 0% | 0% | 0% | 0% | −4.1% | 0% | −0.4% | −3.3% | −6.4% | −469.5% | 39.6% |
| Net Profit | −0 | −0 | −0 | −0 | −1 | 9 | −0 | −19 | −14 | −8 | 12 | 7 |
| EPS in Rs | −0.06 | −0.06 | −0.07 | −0.06 | −0.15 | 2.67 | −0.06 | −5.43 | −4.15 | −0.84 | 1.29 | 0.73 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- 135%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- 74%
- 10 Years
- 36%
- 5 Years
- 64%
- 3 Years
- 86%
- TTM
- —
- 10 Years
- −11%
- 5 Years
- −15%
- 3 Years
- −21%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Innovassynth Technologies (India) Ltd | — | ₹ 1,460 Cr. | 266.7x | 14.3x | −41% | — |
| ICICI Prudential Asset Management Company Ltd | ₹ 2,655.00 | ₹ 1,30,928 Cr. | 47.7x | 37.7x | — | 56% |
| HDFC Asset Management Company | ₹ 2,250.00 | ₹ 96,542 Cr. | 39.9x | 12.3x | — | 69.3% |
| Nippon Life India Asset Management | ₹ 922.10 | ₹ 59,010 Cr. | 50.1x | 16.3x | 34.5% | 56.4% |
| Multi Commodity Exchange Of India | ₹ 3,017.00 | ₹ 76,931 Cr. | 52.6x | 16.6x | 37.9% | 57.8% |
| Motilal Oswal Financial Services | ₹ 925.00 | ₹ 55,715 Cr. | 30.8x | 4.5x | 15.6% | 21.2% |
Management
- Hardik Joshipura
- Chief Executive Officer, Managing Director
- Jayesh Patel
- Chief Financial Officer
- Sameer Pakhali
- Company Secretary
Prices are delayed and for information only. Nothing on this page is investment advice.